You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Biology-driven cancer drug development: back to the future
|
|---|---|
| Published in |
BMC Biology, April 2010
|
| DOI | 10.1186/1741-7007-8-38 |
| Pubmed ID | |
| Authors |
Christopher J Lord, Alan Ashworth |
| Abstract |
Most of the significant recent advances in cancer treatment have been based on the great strides that have been made in our understanding of the underlying biology of the disease. Nevertheless, the exploitation of biological insight in the oncology clinic has been haphazard and we believe that this needs to be enhanced and optimized if patients are to receive maximum benefit. Here, we discuss how research has driven cancer drug development in the past and describe how recent advances in biology, technology, our conceptual understanding of cell networks and removal of some roadblocks may facilitate therapeutic advances in the (hopefully) near future. |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 3% |
| France | 2 | 2% |
| Germany | 2 | 2% |
| United States | 2 | 2% |
| Malaysia | 1 | <1% |
| Slovenia | 1 | <1% |
| South Africa | 1 | <1% |
| Spain | 1 | <1% |
| Argentina | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 117 | 89% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 40 | 30% |
| Student > Ph. D. Student | 20 | 15% |
| Student > Bachelor | 12 | 9% |
| Professor | 11 | 8% |
| Other | 9 | 7% |
| Other | 27 | 20% |
| Unknown | 13 | 10% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 57 | 43% |
| Medicine and Dentistry | 27 | 20% |
| Biochemistry, Genetics and Molecular Biology | 15 | 11% |
| Chemistry | 7 | 5% |
| Computer Science | 4 | 3% |
| Other | 6 | 5% |
| Unknown | 16 | 12% |